Here we determine the molecular and structural biological details of this inhibition, demonstrate using biomarkers that these agents inhibit Hsp90 in cancer cells, and show that they exhibit antiproliferative activity and induce apoptosis in the human colon cancer cell line HCT116. This evidence concerns the gene HSP90AA1 and malignant colon neoplasm.